Alain Sherter is a senior managing editor with CBS News. He covers business, economics, money and workplace issues for CBS MoneyWatch. Trump Media & Technology is merging with fusion energy company ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Altman taps a leading researcher for his brain-computer interface startup, suggesting a much less invasive approach than Elon Musk’s Neuralink. Altman taps a leading researcher for his brain-computer ...

OpenAI co-founder Sam Altman is preparing to back a new brain-computer interface startup called Merge Labs that could be a possible rival to Elon Musk's Neuralink, the Financial Times reported, citing ...

The company laid out its restructuring plans in a regulatory document. These include a workforce reduction of around 20%. Before market open, Recursion disclosed in a tersely worded regulatory filing ...

Evidently in the mood for some spring cleaning, Salt Lake City’s Recursion is clearing out a chunk of its pipeline as it narrows its focus on R&D in oncology and rare diseases. The move comes roughly ...

Elon Musk’s team is leading an effort to link government databases, to the alarm of privacy and security experts. By Emily Badger and Sheera Frenkel The federal government knows your mother’s maiden ...

The market is viewing NVIDIA's decision to keep its 7.7 million share stake in Recursion while divesting from other AI holdings as a significant strategic move. This decision indicates NVIDIA's ...